A drug candidate can spend years moving through discovery, preclinical testing, and clinical development before researchers know whether it will ultimately succeed. That uncertainty is one of the central problems that the Biosimulation Market is increasingly addressing. Instead of relying entirely on physical experiments to understand how a drug may behave, researchers can use...